#drug-manufacturing
(4 articles)Single-Use Manufacturing Risk Mitigation Strategies for Pharma
Single-use manufacturing systems have become critical infrastructure in biopharmaceutical production, yet their concentrated supplier base creates significant supply chain vulnerability. This article
US Drug Supply Exposed: Critical China Dependency Risk
The US pharmaceutical supply chain faces a critical structural vulnerability stemming from significant dependency on China for active pharmaceutical ingredients (APIs) and drug manufacturing. This con
Pharma Supply Chain Resilience Against Tariff Shifts
The pharmaceutical industry faces mounting pressure from volatile trade policies and tariff regimes that threaten cost structures and supply continuity. As tariff policies shift unpredictably—particul
Pharma Industry Faces Tariff Pressure: Peer Survey Results
A peer survey of bio/pharma companies reveals growing concerns regarding tariffs and evolving trade policy, with widespread implications across the industry. Respondents indicate that trade barriers a